GeneOne Life Science, Inc. (011000.KS)
KRW 2035.0
(-3.1%)
KRW 2035.0
(-3.1%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1000.23 KRW | -103.15% |
| 2022 | -492.35 KRW | -129.15% |
| 2021 | -214.86 KRW | 17.01% |
| 2020 | -258.90 KRW | -22.03% |
| 2019 | -212.16 KRW | 29.74% |
| 2018 | -301.98 KRW | 57.38% |
| 2017 | -708.55 KRW | -48.0% |
| 2016 | -478.74 KRW | -1228.31% |
| 2015 | 42.43 KRW | 103.58% |
| 2014 | -1184.66 KRW | -283.53% |
| 2013 | -308.88 KRW | 20.34% |
| 2012 | -387.74 KRW | -65.07% |
| 2011 | -234.90 KRW | 39.24% |
| 2010 | -386.59 KRW | 17.47% |
| 2009 | -468.41 KRW | 2.55% |
| 2008 | -480.68 KRW | -107.97% |
| 2007 | -231.13 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -121.06 KRW | 76.2% |
| 2024 Q2 | -160.41 KRW | -32.5% |
| 2023 FY | - KRW | -103.15% |
| 2023 Q1 | -170.39 KRW | 9.82% |
| 2023 Q2 | -170.19 KRW | 0.12% |
| 2023 Q3 | -148.85 KRW | 12.54% |
| 2023 Q4 | -508.55 KRW | -241.65% |
| 2022 Q2 | -141.65 KRW | -136.08% |
| 2022 Q3 | -102.00 KRW | 27.99% |
| 2022 FY | - KRW | -129.15% |
| 2022 Q4 | -188.94 KRW | -85.24% |
| 2022 Q1 | -60.00 KRW | -80.18% |
| 2021 Q1 | -26.76 KRW | 80.67% |
| 2021 FY | - KRW | 17.01% |
| 2021 Q4 | -33.30 KRW | 58.22% |
| 2021 Q2 | -91.09 KRW | -240.4% |
| 2021 Q3 | -79.71 KRW | 12.49% |
| 2020 Q4 | -138.44 KRW | -271.35% |
| 2020 FY | - KRW | -22.03% |
| 2020 Q3 | -37.28 KRW | 47.27% |
| 2020 Q2 | -70.70 KRW | -10.26% |
| 2020 Q1 | -64.12 KRW | 3.82% |
| 2019 FY | - KRW | 29.74% |
| 2019 Q1 | -11.42 KRW | 84.06% |
| 2019 Q2 | -98.14 KRW | -759.37% |
| 2019 Q3 | -9.35 KRW | 90.47% |
| 2019 Q4 | -66.67 KRW | -613.05% |
| 2018 Q3 | -72.18 KRW | 5.44% |
| 2018 Q4 | -71.65 KRW | 0.73% |
| 2018 Q2 | -76.33 KRW | -2.8% |
| 2018 Q1 | -74.25 KRW | 68.2% |
| 2018 FY | - KRW | 57.38% |
| 2017 Q1 | -149.69 KRW | -10.61% |
| 2017 Q3 | -116.31 KRW | 50.91% |
| 2017 Q4 | -233.48 KRW | -100.74% |
| 2017 FY | - KRW | -48.0% |
| 2017 Q2 | -236.93 KRW | -58.28% |
| 2016 Q4 | -135.33 KRW | 3.11% |
| 2016 FY | - KRW | -1228.31% |
| 2016 Q3 | -139.68 KRW | 9.84% |
| 2016 Q2 | -154.93 KRW | -327.63% |
| 2016 Q1 | -36.23 KRW | -227.87% |
| 2015 Q1 | -25.21 KRW | 84.45% |
| 2015 Q3 | 105.83 KRW | 482.75% |
| 2015 FY | - KRW | 103.58% |
| 2015 Q4 | -11.05 KRW | -110.44% |
| 2015 Q2 | -27.65 KRW | -9.68% |
| 2014 Q4 | -162.15 KRW | 21.81% |
| 2014 FY | - KRW | -283.53% |
| 2014 Q3 | -207.37 KRW | 21.11% |
| 2014 Q2 | -262.87 KRW | -1824.38% |
| 2014 Q1 | -13.66 KRW | 34.58% |
| 2013 Q2 | -113.91 KRW | 18.75% |
| 2013 Q1 | -140.20 KRW | -23.68% |
| 2013 Q3 | -72.29 KRW | 36.54% |
| 2013 Q4 | -20.88 KRW | 71.12% |
| 2013 FY | - KRW | 20.34% |
| 2012 FY | - KRW | -65.07% |
| 2012 Q2 | -109.53 KRW | -147.08% |
| 2012 Q3 | -59.15 KRW | 46.0% |
| 2012 Q4 | -113.36 KRW | -91.65% |
| 2012 Q1 | -44.33 KRW | 58.06% |
| 2011 Q3 | -5.68 KRW | 90.95% |
| 2011 FY | - KRW | 39.24% |
| 2011 Q2 | -62.73 KRW | -219.4% |
| 2011 Q1 | -19.64 KRW | 95.47% |
| 2011 Q4 | -105.69 KRW | -1760.74% |
| 2010 FY | - KRW | 17.47% |
| 2010 Q3 | -110.45 KRW | -285.65% |
| 2010 Q2 | -28.64 KRW | 26.3% |
| 2010 Q1 | -38.86 KRW | 65.17% |
| 2010 Q4 | -433.35 KRW | -292.35% |
| 2009 Q2 | -259.77 KRW | -332.45% |
| 2009 Q3 | -118.64 KRW | 54.33% |
| 2009 Q4 | -111.56 KRW | 5.97% |
| 2009 FY | - KRW | 2.55% |
| 2009 Q1 | -60.07 KRW | 77.0% |
| 2008 Q3 | -36.82 KRW | 66.04% |
| 2008 Q4 | -261.17 KRW | -609.32% |
| 2008 FY | - KRW | -107.97% |
| 2008 Q2 | -108.41 KRW | -47.22% |
| 2008 Q1 | -73.64 KRW | 30.5% |
| 2007 Q4 | -105.96 KRW | -72.18% |
| 2007 Q2 | -108.41 KRW | -353.18% |
| 2007 Q3 | -61.54 KRW | 43.23% |
| 2007 Q1 | 42.82 KRW | 0.0% |
| 2007 FY | - KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ORIENT BIO Inc. | 108.55 KRW | 1021.446% |
| Green Cross Holdings Corporation | -1210.00 KRW | 17.336% |
| Green Cross Holdings Corporation | -2333.42 KRW | 57.135% |
| Pharmicell Co., Ltd. | 60.00 KRW | 1767.05% |
| Green Cross Corporation | -2333.42 KRW | 57.135% |
| Celltrion, Inc. | 3759.00 KRW | 126.609% |
| Samsung Biologics Co.,Ltd. | 12.05 Thousand KRW | 108.301% |
| SK bioscience Co.,Ltd. | 291.00 KRW | 443.722% |
| SK Biopharmaceuticals Co., Ltd. | -419.89 KRW | -138.212% |
| Prestige BioPharma Limited | -547.81 KRW | -82.587% |